Cart
sales@molnova.com
Voacamine
CAS No. 3371-85-5
Voacamine( Voacanginine )
Catalog No. M24284 CAS No. 3371-85-5
Voacamine is an indole alkaloid. Voacamine exhibits potent cannabinoid CB1 receptor antagonistic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 249 | In Stock |
|
| 10MG | 426 | In Stock |
|
| 25MG | 683 | In Stock |
|
| 50MG | 888 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVoacamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionVoacamine is an indole alkaloid. Voacamine exhibits potent cannabinoid CB1 receptor antagonistic activity.
-
DescriptionVoacamine is an indole alkaloid. Voacamine exhibits potent cannabinoid CB1 receptor antagonistic activity. Voacamine also inhibits P-glycoprotein (P-gp) action in multidrug-resistant tumor cells.Voacanginine may have rhythmic effects.
-
In Vitro——
-
In Vivo——
-
SynonymsVoacanginine
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorCB1|P-gp
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3371-85-5
-
Formula Weight704.91
-
Molecular FormulaC43H52N4O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO=C(C1(C(C(C2)CC)N3CC2C1)C4=C(CC3)C(C=C(OC)C([C@H](CC(/C(CN5C)=C/C)C(C(OC)=O)[C@H]5C6)C7=C6C(C=CC=C8)=C8N7)=C9)=C9N4)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Condello M , Pellegrini E , Multari G , et al. Voacamine: Alkaloid with its essential dimeric units to reverse tumor multidrug resistance[J]. Toxicology in Vitro, 2020, 65:104819.
molnova catalog
related products
-
LY2828360
LY2828360 is a cannabinoid (CB) receptor 2 agonist (Ki = 40.3 nM). It selectively activates CB2 over CB1 in a GTPγS binding assay (EC50s = 20.1 and >100000 nM respectively).
-
Fatostatin
Fatostatin ia an inhibitor of sterol regulatory element binding protein (SREBP). It impairs the activation of SREBP-1 and SREBP-2.
-
RVD-Hpα
N-terminally extended form of human hemopressin that acts as a selective CB1 receptor agonist. Increases intracellular Ca2+ levels in cells expressing CB1 receptors in vitro. Also high affinity CB2 positive allosteric modulator (Ki = 50 nM).
